NHPNational Healthcare Properties, Inc. (NHP)Real Estate · REIT - Healthcare Facilitiesas of 2026-09-16
Horizon

Issued 2026-09-16 at $16.12 · now $16.12 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, NHP has typically landed between $14.85 and $18.65 — a range of −7.9% to +15.7% from the issuance price $16.12.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

81 overlapping 1 month windows · 2026-04-222026-08-17 · basis climatology · forecast (batch).

The cone is anchored at the 2026-09-16 issuance close ($16.12) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where NHP has typically landed a month from the 2026-09-16 close of $16.12 — the range is history, not a prediction.

$14.85worst · -7.9%$18.65best · +15.7%
  • now $16.12 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $16.98 (+5.3%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $16.28$17.68
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $14.85$18.65
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 81 windows spanning 2026-04-22 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2026-05-18−10.3%−10.4%+0.0%
2026-05-15−9.3%−9.3%+1.2%
2026-05-14−4.7%−4.7%+4.0%
3 best
2026-04-22+21.5%+0.0%+25.3%
2026-06-16+18.3%+0.0%+18.3%
2026-04-23+17.8%+0.0%+20.3%

81 overlapping windows · 2026-04-222026-09-16 · not cherry-picked

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$17$12↑ buys↓ sales
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

18 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-08-17Campbell Albert M IIIdirectorAward / grant4,6935,383Form 4
2026-05-15Penn Buddie JdirectorAward / grant7,44619,946Form 4
2026-05-15Weil Edward M Jr.directorAward / grant7,44619,946Form 4
2026-05-15Humphrey ScottdirectorAward / grant9,93522,435Form 4
2026-05-15MICHELSON LESLIE DdirectorAward / grant7,44619,946Form 4
2026-05-15Tuppeny Elizabeth K.directorAward / grant7,44619,946Form 4
2026-04-30BABIN ANDREW T.officerAward / grant41,667191,095Form 4
2026-04-30Rendell Edward GdirectorAward / grant12,50024,075Form 4
2026-04-30Tuppeny Elizabeth K.directorAward / grant12,50012,500Form 4
2026-04-30Penn Buddie JdirectorAward / grant12,50012,500Form 4
2026-04-30Anderson Michael RaydirectorAward / grant348,665348,665Form 4
2026-04-30Anderson Michael RaydirectorAward / grant75,000423,665Form 4
2026-04-30PARK AILIN SEEofficerAward / grant25,00025,000Form 4
2026-04-30PARK AILIN SEEofficerAward / grant5,20930,209Form 4
2026-04-30MICHELSON LESLIE DdirectorAward / grant12,50012,500Form 4
2026-04-30Weil Edward M Jr.directorAward / grant12,50012,500Form 4
2026-04-30Humphrey ScottdirectorAward / grant12,50012,500Form 4
2026-04-30BABIN ANDREW T.officerAward / grant149,428149,428Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.